We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Targeting Headaches and Tumors with Nano-Submarines

News   Jul 20, 2018 | Original story from Johannes Gutenberg University Mainz

 
Targeting Headaches and Tumors with Nano-Submarines

Combining a tiny drug capsule -- a nanocarrier -- with antibodies under acidic conditions results in the antibodies attaching to the drug carrier in a stable way. This makes it possible for nanocarriers to target diseased tissue. Credit: Stefan Schuhmacher

 
 
 

RELATED ARTICLES

Therapy Combo Promising in Small Cell Lung Cancer Model

News

A combination of immune checkpoint blockade and targeted therapies that block normal DNA damage repair achieved significant tumor regression in mouse models of small cell lung cancer, suggesting a promising new approach for treating patients with this aggressive cancer.

READ MORE

Open Science Drug Discovery Approach Targets Neurodegenerative Disease

News

Parkinson’s disease and Amyotrophic Lateral Sclerosis, or ALS, are the newest frontiers for open science drug discovery, a global movement led by University of Toronto researchers that puts knowledge sharing and medication affordability ahead of patents and profits.

READ MORE

Graphene Wearables Could Have Broad Monitoring Appeal

News

A wearable, flexible, transparent and disposable patch which connects to a mobile device and alerts the user once he or she has reached a defined threshold of sun exposure, could have wide applications in health monitoring and food inspection.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE